Certified by Founder Lodge
ErVimmune
- ND
START UP
1 Disclosed Funding Rounds $19,917,795
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Targeting shared unconventional tumor antigens in cancer immunotherapy
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 21 ,2026 | Series A | $19,917,795 |
Seventure Partners
SPRIM Global Investments
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Formulary Financial | $4,600,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
